Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

11814389001

Roche

Red Blood Cell Lysis Buffer

solution, Roche, pkg of 100 mL, sufficient for 50-500 reactions

Synonym(s):

RBC Lysis Buffer, lysis buffer, red blood cells

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
23201100

form

solution

usage

sufficient for 50-500 reactions

packaging

pkg of 100 mL

manufacturer/tradename

Roche

storage temp.

2-8°C

General description

Used for both DNA and RNA isolation, the buffer is designed for the preferential lysis of red blood cells from human whole blood, yielding intact white blood cells (free of red blood cells) for further applications. This buffer is not intended for use with whole blood from any other species.

Application

Red blood cell lysis buffer has been used in the isolation of PBMCs (peripheral blood mononuclear cells) from HIV infected patients. It has also been used in the isolation of lung cellsm, naive CD8+ T cells and infected cells from the lung.
Used for both DNA and RNA isolation, the buffer is designed for the preferential lysis of red blood cells from human whole blood, yielding intact white blood cells (free of red blood cells) for use in further research applications.
It has been used for the lysis of blood cells in femoral bone marrow, PBMC (peripheral blood mononuclear cells) and human lung adenocarcinoma samples.

Physical form

Ready-to-use solution.

Other Notes

For life science research only. Not for use in diagnostic procedures.

wgk_germany

nwg

flash_point_f

No data available

flash_point_c

No data available


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Methylthioadenosine (MTA) Rescues Methylthioadenosine Phosphorylase (MTAP)-deficient tumors from purine synthesis inhibition in vivo via non-autonomous adenine supply.
Ruefli-Brasse A
Journal of Cancer Therapy (2011)
Dual Specificity Phosphatase 5 Is Essential for T Cell Survival
Kutty RG, et al.
PLoS ONE, 11(12), 0167246-0167246 (2016)
Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry
Van Kampen JJ, et al.
PLoS ONE, 5(7), 11409-11409 (2010)
Jeroen J A van Kampen et al.
PloS one, 5(7), e11409-e11409 (2010-07-14)
HIV protease inhibitors must penetrate into cells to exert their action. Differences in the intracellular pharmacokinetics of these drugs may explain why some patients fail on therapy or suffer from drug toxicity. Yet, there is no information available on the
A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles
Ramirez A, et al.
Vaccine (2018)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service